327 related articles for article (PubMed ID: 26297440)
1. Animal model for medication-related osteonecrosis of the jaw with precedent metabolic bone disease.
Kim JW; Tatad JCI; Landayan MEA; Kim SJ; Kim MR
Bone; 2015 Dec; 81():442-448. PubMed ID: 26297440
[TBL] [Abstract][Full Text] [Related]
2. Role of microcracks in the pathogenesis of bisphosphonate-related osteonecrosis of the jaw.
Kim JW; Landayan ME; Lee JY; Tatad JC; Kim SJ; Kim MR; Cha IH
Clin Oral Investig; 2016 Nov; 20(8):2251-2258. PubMed ID: 26795624
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers for Bisphosphonate-Related Osteonecrosis of the Jaw.
Kim JW; Cha IH; Kim SJ; Kim MR
Clin Implant Dent Relat Res; 2016 Apr; 18(2):281-91. PubMed ID: 25726720
[TBL] [Abstract][Full Text] [Related]
4. Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model.
Ersan N; van Ruijven LJ; Bronckers AL; Olgaç V; Ilgüy D; Everts V
Dentomaxillofac Radiol; 2014; 43(1):20130144. PubMed ID: 24170800
[TBL] [Abstract][Full Text] [Related]
5. Zoledronic acid - related osteonecrosis of the jaws. Experimental model with dental extractions in rats.
Barba-Recreo P; Del Castillo Pardo de Vera JL; García-Arranz M; Yébenes L; Burgueño M
J Craniomaxillofac Surg; 2014 Sep; 42(6):744-50. PubMed ID: 24342733
[TBL] [Abstract][Full Text] [Related]
6. Effects of pH alteration on the pathogenesis of medication-related osteonecrosis of the jaw.
Kim JW; Alfafara AMD; Kim HY; Kim SY; Kim SJ
Bone; 2019 May; 122():45-51. PubMed ID: 30738857
[TBL] [Abstract][Full Text] [Related]
7. Periapical disease and bisphosphonates induce osteonecrosis of the jaws in mice.
Kang B; Cheong S; Chaichanasakul T; Bezouglaia O; Atti E; Dry SM; Pirih FQ; Aghaloo TL; Tetradis S
J Bone Miner Res; 2013 Jul; 28(7):1631-40. PubMed ID: 23426919
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of BP-ONJ in osteopenic and healthy sheep: comparing ZTE-MRI with µCT.
Voss P; Ludwig U; Poxleitner P; Bergmaier V; El-Shafi N; von Elverfeldt D; Stadelmann V; Hövener JB; Flügge T
Dentomaxillofac Radiol; 2016; 45(4):20150250. PubMed ID: 26846710
[TBL] [Abstract][Full Text] [Related]
9. OPG-Fc but Not Zoledronic Acid Discontinuation Reverses Osteonecrosis of the Jaws (ONJ) in Mice.
de Molon RS; Shimamoto H; Bezouglaia O; Pirih FQ; Dry SM; Kostenuik P; Boyce RW; Dwyer D; Aghaloo TL; Tetradis S
J Bone Miner Res; 2015 Sep; 30(9):1627-40. PubMed ID: 25727550
[TBL] [Abstract][Full Text] [Related]
10. Histopathological Effects of Teriparatide in Medication-Related Osteonecrosis of the Jaw: An Animal Study.
Keskinruzgar A; Bozdag Z; Aras MH; Demir T; Yolcu U; Cetiner S
J Oral Maxillofac Surg; 2016 Jan; 74(1):68-78. PubMed ID: 26215490
[TBL] [Abstract][Full Text] [Related]
11. Osteonecrosis of the Jaw Developed in Mice: DISEASE VARIANTS REGULATED BY γδ T CELLS IN ORAL MUCOSAL BARRIER IMMUNITY.
Park S; Kanayama K; Kaur K; Tseng HC; Banankhah S; Quje DT; Sayre JW; Jewett A; Nishimura I
J Biol Chem; 2015 Jul; 290(28):17349-66. PubMed ID: 26013832
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapeutic and antiresorptive combination therapy suppressed lymphangiogenesis and induced osteonecrosis of the jaw-like lesions in mice.
Kuroshima S; Yamashita J
Bone; 2013 Sep; 56(1):101-9. PubMed ID: 23727433
[TBL] [Abstract][Full Text] [Related]
13. Zoledronate induces bisphosphonate-related osteonecrosis of the jaw in osteopenic sheep.
Voss PJ; Stoddart MJ; Bernstein A; Schmelzeisen R; Nelson K; Stadelmann V; Ziebart T; Poxleitner PJ
Clin Oral Investig; 2016 Jan; 20(1):31-8. PubMed ID: 25843053
[TBL] [Abstract][Full Text] [Related]
14. Increased prevalence of bisphosphonate-related osteonecrosis of the jaw with vitamin D deficiency in rats.
Hokugo A; Christensen R; Chung EM; Sung EC; Felsenfeld AL; Sayre JW; Garrett N; Adams JS; Nishimura I
J Bone Miner Res; 2010 Jun; 25(6):1337-49. PubMed ID: 20200938
[TBL] [Abstract][Full Text] [Related]
15. Antiresorptive Agent-Related Osteonecrosis of the Jaw (ARONJ): A Twist of Fate in the Bone.
Shibahara T
Tohoku J Exp Med; 2019 Feb; 247(2):75-86. PubMed ID: 30713280
[TBL] [Abstract][Full Text] [Related]
16. Dental extraction following zoledronate, induces osteonecrosis in rat's jaw.
Vidal-Gutiérrez X; Gómez-Clavel JF; Gaitán-Cepeda LA
Med Oral Patol Oral Cir Bucal; 2017 Mar; 22(2):e177-e184. PubMed ID: 28160593
[TBL] [Abstract][Full Text] [Related]
17. Role of periodontal disease in bisphosphonate-related osteonecrosis of the jaws in ovariectomized rats.
Li CL; Lu WW; Seneviratne CJ; Leung WK; Zwahlen RA; Zheng LW
Clin Oral Implants Res; 2016 Jan; 27(1):1-6. PubMed ID: 25371026
[TBL] [Abstract][Full Text] [Related]
18. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
[TBL] [Abstract][Full Text] [Related]
19. Prevention of osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates.
DE Iuliis F; Taglieri L; Amoroso L; Vendittozzi S; Blasi L; Salerno G; Lanza R; Scarpa S
Anticancer Res; 2014 May; 34(5):2477-80. PubMed ID: 24778063
[TBL] [Abstract][Full Text] [Related]
20. Altered microRNA expression profile in the peripheral lymphoid compartment of multiple myeloma patients with bisphosphonate-induced osteonecrosis of the jaw.
Musolino C; Oteri G; Allegra A; Mania M; D'Ascola A; Avenoso A; Innao V; Allegra AG; Campo S
Ann Hematol; 2018 Jul; 97(7):1259-1269. PubMed ID: 29546453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]